November 17, 2017

Telephus Medical Founder Awarded $6 Million NIH Grant to Expand Translational Research in Bone Infections

November 16, 2017

Retrotope initiates second patient for Compassionate Use of RT001 for an ultrarare genetic neurological disease, Infantile Neuroaxonal Dystrophy.

October 4, 2017

Zavante Therapeutics Presents Additional Clinical and Microbiologic Data From ZOLYD™ Phase 2/3 Trial at ID Week 2017

September 8, 2017

Zavante Therapeutics Announces Agreement With NIAID To Assess ZOLYD™ For Lower Respiratory Tract Infections

Oncternal Therapeutics: UCSD cancer clinical trial gets $18.2 million

June 6, 2017

Zavante Therapeutics Presents Positive Results From NIH-Sponsored ZOLYD™ Phase 1 Trial At ASM Microbe 2017 Meeting

May 15, 2017

Genoa Pharmaceuticals Secures $62 Million Series A Financing, Adds to Leadership Team

May 8, 2017

Retrotope Chairman, Dr. Harry J. Saal, highlights the ideas and concepts behind Retrotope’s technology at TEDxPaloAlto

April 5, 2017

Zavante Therapeutics’ ZOLYD™ Met Primary Endpoint in Pivotal ZEUS Study for Treatment of Complicated Urinary Tract Infections

February 22, 2017

Oncternal Closes $18.4 Million Series B Financing